These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 25562555

  • 1. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
    Klimek L, Bachert C, Mösges R, Munzel U, Price D, Virchow JC, Wahn U, Bousquet J.
    Allergy Asthma Proc; 2015; 36(1):40-7. PubMed ID: 25562555
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
    Bousquet J, Bachert C, Bernstein J, Canonica GW, Carr W, Dahl R, Demoly P, Devillier P, Hellings P, Fokkens W, Klimek L, Lieberman P, Meltzer E, Price D, Ryan D, Wahn U.
    Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
    [Abstract] [Full Text] [Related]

  • 4. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
    Klimek L, Bousquet J, Price D.
    Expert Opin Drug Saf; 2016 Jan; 15(1):117-29. PubMed ID: 26581312
    [Abstract] [Full Text] [Related]

  • 5. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA, Jacobsen C, Christensen ME.
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [Abstract] [Full Text] [Related]

  • 6. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.
    Carr W, Bernstein J, Lieberman P, Meltzer E, Bachert C, Price D, Munzel U, Bousquet J.
    J Allergy Clin Immunol; 2012 May; 129(5):1282-1289.e10. PubMed ID: 22418065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.
    Price D, Shah S, Bhatia S, Bachert C, Berger W, Bousquet J, Carr W, Hellings P, Munzel U, Scadding G, Lieberman P.
    J Investig Allergol Clin Immunol; 2013 May; 23(7):495-503. PubMed ID: 24654314
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
    Agache I, Doros IC, Leru PM, Bucur I, Poenaru M, Sarafoleanu C.
    Rhinology; 2018 Mar 01; 56(1):33-41. PubMed ID: 28942457
    [Abstract] [Full Text] [Related]

  • 11. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.
    Klimek L, Bachert C, Stjärne P, Dollner R, Larsen P, Haahr P, Agache I, Scadding G, Price D.
    Allergy Asthma Proc; 2016 Sep 01; 37(5):376-86. PubMed ID: 27657521
    [Abstract] [Full Text] [Related]

  • 12. Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
    Berger WE, Shah S, Lieberman P, Hadley J, Price D, Munzel U, Bhatia S.
    J Allergy Clin Immunol Pract; 2014 Sep 01; 2(2):179-85. PubMed ID: 24607046
    [Abstract] [Full Text] [Related]

  • 13. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L, Price D, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, van Weissenbruch R, Pohl W, Kuhl HC, Scadding G, Mullol J.
    Int Arch Allergy Immunol; 2020 Sep 01; 181(10):754-764. PubMed ID: 32829329
    [Abstract] [Full Text] [Related]

  • 14. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012 Sep 01; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 15. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R, Nguyen DT, Kuhl HC.
    Immun Inflamm Dis; 2018 Dec 01; 6(4):456-464. PubMed ID: 30306729
    [Abstract] [Full Text] [Related]

  • 16. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
    Derendorf H, Munzel U, Petzold U, Maus J, Mascher H, Hermann R, Bousquet J.
    Br J Clin Pharmacol; 2012 Jul 01; 74(1):125-33. PubMed ID: 22356350
    [Abstract] [Full Text] [Related]

  • 17. Control of allergic rhinitis with MP-AzeFlu: a noninterventional study of a Swedish cohort.
    Stjarne P, Strand V, Theman K, Ehnhage A.
    Rhinology; 2019 Aug 01; 57(4):279-286. PubMed ID: 30938376
    [Abstract] [Full Text] [Related]

  • 18. A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.
    Ridolo E, Montagni M, Melli V, Bonzano L, Incorvaia C, Canonica GW.
    Ther Deliv; 2015 Aug 01; 6(6):653-9. PubMed ID: 25913181
    [Abstract] [Full Text] [Related]

  • 19. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis.
    Kortekaas Krohn I, Callebaut I, Alpizar YA, Steelant B, Van Gerven L, Skov PS, Kasran A, Talavera K, Wouters MM, Ceuppens JL, Seys SF, Hellings PW.
    Allergy; 2018 May 01; 73(5):1084-1093. PubMed ID: 29121401
    [Abstract] [Full Text] [Related]

  • 20. Clinical development of an advanced intranasal delivery system of azelastine hydrochloride and fluticasone propionate.
    Derendorf H, Meltzer EO, Hermann R, Canonica GW.
    Drugs Today (Barc); 2014 Jan 01; 50(1):15-31. PubMed ID: 24524103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.